FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Komarek Luke
2. Issuer Name and Ticker or Trading Symbol

CHRISTOPHER & BANKS CORP [ CBK ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP, General Counsel
(Last)          (First)          (Middle)

2400 XENIUM LANE NORTH
3. Date of Earliest Transaction (MM/DD/YYYY)

3/31/2017
(Street)

PLYMOUTH, MN 55441
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/31/2017     P    1250   A $1.50   75761   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   $17.63                    5/21/2008   (2) 5/21/2017   Common Stock   9500.0     9500   D    
Employee Stock Option (Right to Buy)   $13.31                    10/30/2008   (3) 10/30/2017   Common Stock   6000.0     6000   D    
Employee Stock Option (Right to Buy)   $10.56                    4/14/2009   (4) 4/14/2018   Common Stock   7500.0     7500   D    
Employee Stock Option (Right to Buy)   $4.18                    4/13/2010   (5) 4/13/2019   Common Stock   35000.0     35000   D    
Employee Stock Option (Right to Buy)   $10.8                    4/19/2011   (6) 4/19/2020   Common Stock   21200.0     21200   D    
Employee Stock Option (Right to Buy)   $6.28                    4/18/2012   (7) 4/18/2021   Common Stock   26236.0     26236   D    
Employee Stock Option (Right to Buy)   $1.91                    3/29/2013   (8) 3/29/2022   Common Stock   35749.0     35749   D    
Employee Stock Option (Right to Buy)   $6.25                    3/15/2014   (9) 3/15/2023   Common Stock   9039.0     9039   D    
Employee Stock Option (Right to Buy)   $2.12                    9/1/2017   (10) 9/1/2026   Common Stock   86019.0     86019   D    
Employee Stock Option (Right to Buy)   $1.28                    3/16/2018   (11) 3/16/2027   Common Stock   75000.0     75000   D    

Explanation of Responses:
( 1)  This number includes restricted stock awards.
( 2)  On May 21, 2007, the reporting person was granted an option to purchase 9,500 shares of Common Stock. The option vests equally in three annual installments beginning on May 21, 2008.
( 3)  On October 30, 2007, the reporting person was granted an option to purchase 6,000 shares of Common Stock. The option vests equally in three annual installments beginning on October 30, 2008.
( 4)  On April 14, 2008, the reporting person was granted an option to purchase 7,500 shares of Common Stock. The option vests equally in three annual installments beginning on April 14, 2009.
( 5)  On April 13, 2009, the reporting person was granted an option to purchase 35,000 shares of Common Stock. The option vests equally in five annual installments of 7,000 shares beginning on April 13, 2010.
( 6)  On April 19, 2010, the reporting person was granted an option to purchase 21,200 shares of Common Stock. The option vests in three annual installments of 7,066 shares on April 19, 2011, 7,067 shares on April 19, 2012 and 7,067 shares on April 19, 2013.
( 7)  On April 18, 2011, the reporting person was granted an option to purchase 26,236 shares of Common Stock. The option vests in three annual installments of 8,746 shares on April 18, 2012, 8,745 shares on April 18, 2013 and 8,745 shares on April 18, 2014.
( 8)  On March 29, 2012, the reporting person was granted an option to purchase 35,749 shares of Common Stock. The option vests in three annual installments of 11,917 shares on March 29, 2013, 11,916 shares on March 29, 2014 and 11,916 shares on March 29, 2015.
( 9)  On March 15, 2013, the reporting person was granted an option to purchase 9,039 shares of the Company's Common Stock. The option vests in three annual installments of 3,013 shares on each of March 15, 2014, March 15, 2015 and March 15, 2016.
( 10)  On September 1, 2016, the reporting person was granted an option to purchase 86,019 shares of the Company's Common Stock. The option vests in three annual installments of 28,673 shares on each of September 1, 2017, September 1, 2018 and September 1, 2019.
( 11)  On March 16, 2017, the reporting person was granted an option to purchase 75,000 shares of the Company's Common Stock. The option vests in three annual installments of 25,000 shares on each of March 16, 2018, March 16, 2019 and March 16, 2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Komarek Luke
2400 XENIUM LANE NORTH
PLYMOUTH, MN 55441


SVP, General Counsel

Signatures
/s/Brook T. Nuernberg, Attorney-in-Fact 4/3/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.